Gene expression profiling of benign and malignant pheochromocytoma.
about
Murine models and cell lines for the investigation of pheochromocytoma: applications for future therapies?Evidence of perturbations of cell cycle and DNA repair pathways as a consequence of human and murine NF1-haploinsufficiencyIntegrative epigenomic and genomic analysis of malignant pheochromocytoma.MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas.Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatmentAssociation of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes.Succinate dehydrogenase gene mutations in cardiac paragangliomasPlasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature.Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas.Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomasAnti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cellsDifferential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma.Role of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features.Development of differential diagnosis for benign and malignant pheochromocytomas.Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma.Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy.Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues.The Roles of PI3K/AKT/mTOR and MAPK/ERK Signaling Pathways in Human Pheochromocytomas.Update on tumours of the adrenal cortex, phaeochromocytoma and extra-adrenal paraganglioma.Pheochromocytomas and paragangliomas: assessment of malignant potential.Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification.From transcriptional profiling to tumor biology in pheochromocytoma and paraganglioma.Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.Gene expression profiles of phaeochromocytomas with ERBB2 overexpression reveal a new molecular mechanism tumourigenicity.Role of (18)F-FDG PET/CT, (123)I-MIBG SPECT, and CT in Restaging Patients Affected by Malignant Pheochromocytoma.
P2860
Q26828446-D780726C-577D-48AC-A4AE-580DA9E74056Q33544002-D00F9358-3C0B-4D9F-A1A6-E12EEAE5700CQ34029818-CF72CA0B-9FC7-46E0-88E7-3C1E823433F7Q34136208-1B13667E-86B9-4B09-9F7B-5AEB52285699Q34410500-DFB97E4B-B501-48AA-BD14-FA027A7BD66FQ35562799-9BE636DB-88D0-4CD7-B02A-04D493F4C831Q35668495-A0E345CA-ADE0-4283-A818-5F52FE2A7F13Q36024376-AB29B3FB-558B-45A0-8772-7624E8460BBAQ36421897-D50484B0-1607-4A80-9919-324139E0DF37Q36467140-49C1FAAA-321A-4809-8DC2-F85001D97F6CQ36804496-61AC26A5-FB05-4429-9EB3-21209421903FQ36948906-2F7596C6-A5AB-4512-8A79-981BDF559F61Q36976973-A3FDBD8D-D02C-4CAE-B2F9-A4EB979AD520Q37202015-2023C111-A8CB-4F8C-8EC9-C6F213B37985Q37225700-FF1A60B5-65D0-4904-A685-782786DECF57Q37269244-C08A4520-802C-40BA-8A2D-EB92C19D9DB0Q37315697-4E78AA42-6963-4502-8A01-77AF2CF5167FQ37323454-F005AB63-68FD-4B40-AC93-CA883ABCE5C6Q37470890-AF8B3A42-D576-4EB1-8F4C-4C1AB41E3C7FQ37780798-3FE7E1C1-1B45-49A8-A5C0-9DB1CFDABA1AQ37950920-A0CD072C-6B57-4140-8903-AF8066086365Q37969708-F31B2E10-B885-4E94-9AF4-1EE88D4EFDFDQ37983021-67A1EA81-C07B-4D9C-AFF3-AEE7ABDB9FD3Q37990768-8D90A7E1-38E7-4054-952F-45C265CB4521Q38497926-6CD8424B-18E3-4E46-9E4E-6D039BFE772BQ40220190-0407E8F6-61D1-422C-A870-A83DFD11CDA2
P2860
Gene expression profiling of benign and malignant pheochromocytoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Gene expression profiling of benign and malignant pheochromocytoma.
@en
type
label
Gene expression profiling of benign and malignant pheochromocytoma.
@en
prefLabel
Gene expression profiling of benign and malignant pheochromocytoma.
@en
P2093
P2860
P50
P356
P1476
Gene expression profiling of benign and malignant pheochromocytoma.
@en
P2093
Abdel G Elkahloun
Barry L Shulkin
Frederieke M Brouwers
Graeme Eisenhofer
Idris T Ocal
Jacques W M Lenders
Jennifer Barb
Lucia Ksinantova
Peter J Munson
P2860
P304
P356
10.1196/ANNALS.1353.058
P407
P577
2006-08-01T00:00:00Z